These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9036614)

  • 1. [The prognostic factors in bladder cancer patients].
    al-Shukri SKh; Korneev IA
    Urol Nefrol (Mosk); 1996; (6):49-53. PubMed ID: 9036614
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic delay and prognosis in invasive bladder cancer.
    Liedberg F; Anderson H; Månsson A; Månsson W
    Scand J Urol Nephrol; 2003; 37(5):396-400. PubMed ID: 14594688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender, racial and age differences in bladder cancer incidence and mortality.
    Madeb R; Messing EM
    Urol Oncol; 2004; 22(2):86-92. PubMed ID: 15082003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer of the urinary bladder: prognosis of the outcome].
    Zimichev AA; Prianichnikova MB; Maklakov VN
    Urologiia; 2009; (3):52-3. PubMed ID: 19673123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E; Souhami L; Tanguay S; Rajan R
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of micro-vessel density in cancer of the urinary bladder.
    Chaudhary R; Bromley M; Clarke NW; Betts CD; Barnard RJ; Ryder WD; Kumar S
    Anticancer Res; 1999; 19(4C):3479-84. PubMed ID: 10629639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors of invasive bladder cancer with lymph node invasion].
    Lacroix B; Rusch P; Cerisier A; Pages A; Armand C; Tostain J
    Prog Urol; 2002 Sep; 12(4):615-20. PubMed ID: 12463120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancer.
    Berggren de Verdier PJ; Kumar R; Adolfsson J; Larsson P; Norming U; Onelöv E; Wijkström H; Steineck G; Hemminki K
    Scand J Urol Nephrol; 2006; 40(5):363-9. PubMed ID: 17060081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer.
    Aoki S; Yamada Y; Nakamura K; Taki T; Tobiume M; Honda N
    Oncol Rep; 2006 Aug; 16(2):279-84. PubMed ID: 16820903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the prognosis for cancer of the bladder].
    Cooper EH; Anderson CK
    J Radiol Electrol Med Nucl; 1974 Nov; 55(11):814-5. PubMed ID: 4452963
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion.
    Andius P; Johansson SL; Holmäng S
    Urology; 2007 Oct; 70(4):758-62. PubMed ID: 17991551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups.
    Millán-Rodríguez F; Chéchile-Toniolo G; Salvador-Bayarri J; Huguet-Pérez J; Vicente-Rodríguez J
    J Urol; 2000 Oct; 164(4):1183-7. PubMed ID: 10992362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node assessment and lymphadenectomy in bladder cancer.
    Sharir S; Fleshner NE
    J Surg Oncol; 2009 Mar; 99(4):225-31. PubMed ID: 19235178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical study of superficial bladder cancer with grade 3 components].
    Iiyama T; Hariu K; Kawai M; Kamiyama Y; Okano Y; Shimizu H; Tomomasa H; Iizumi T; Yazaki T; Umeda T
    Hinyokika Kiyo; 1998 Jun; 44(6):375-9. PubMed ID: 9719934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
    Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
    Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
    Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S
    Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
    Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
    BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the association between delay in diagnosis and decreased survival in bladder cancer.
    Porter MP
    Cancer; 2010 Nov; 116(22):5122-5. PubMed ID: 20665888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.